Skip to main content
S 2933 108th Congress Senate Health Administrative procedure Auditing Clinical trials Commerce Communication in medicine Congress Congressional reporting requirements Data banks Department of Health and Human Services Drug advertising Drug approvals Drug industry Fines (Penalties) Government Operations and Politics Government paperwork Governmental investigations Health information systems Law Medical research

FACT Act

Introduced: October 7, 2004 See on congress.gov
This bill died when the 108th Congress ended
It never became law before the 108th Congress (2003–2004) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 7, 2004
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Oct 7, 2004
Sponsor introductory remarks on measure. (CR S10728-10730)
Oct 7, 2004
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Fair Access to Clinical Trials Act of 2004 or the FACT Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH), to establish and operate a data bank of registry information on clinical trials for drugs, biological products, and devices.

Requires the principal investigator or a responsible person to submit clinical trial information to the Secretary.

Requires the Secretary to: (1) seek a memorandum of understanding with the heads of other Federal agencies to include in the registry clinical trials sponsored by such agencies; and (2) establish procedures to allow voluntary submission of clinical trial information not involving drugs, biological products, or devices.

Allows the Secretary to: (1) require that information from such other clinical trials be submitted to the registry in cases in which it is in the interest of public health; and (2) correct any information included in the registry that is factually and substantively inaccurate, false, or misleading.

Extends requirements of this Act to clinical trials conducted outside of the United States under certain circumstances.

Requires the responsible person for proposals submitted to the Secretary requesting financial assistance to conduct research to submit registry information to the Secretary.

Prohibits a responsible person or a manufacturer from performing any act that prohibits, limits, or imposes unreasonable delays on the ability of an individual to discuss or publish the results of a clinical trial.

Requires the Secretary to enter into a contract with the Institute of Medicine to study the extent to which data submitted to the registry has impacted the public health.

What's happening now October 7, 2004

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2933: FACT Act. 108th Congress. Open America. https://openamerica.io/bill/108-S-2933/
MLA
"S. 2933: FACT Act." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-S-2933/.
Bluebook (legal)
S. 2933, 108th Cong. (2026), https://openamerica.io/bill/108-S-2933/.
Markdown link
[S. 2933: FACT Act](https://openamerica.io/bill/108-S-2933/)
Report a problem